CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Implication of hepatocyte dedifferentiation in pathogenesis and treatment of hepatocellular carcinoma
Hyun-Soo Kim, Eun-Ji Park, Chang-Woo Lee


Excel Download

Introductory Chapter: Etiology and Pathogenesis of Hepatocellular Carcinoma
Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018;   Crossref logo

Treatment algorithm for hepatocellular carcinoma
Hepatology Research. 2010;40:8-9   Crossref logo

Molecular Pathogenesis of Hepatocellular Carcinoma
Alcoholism: Clinical and Experimental Research. 2011;35(5):821-825   Crossref logo

Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma
Digestive Diseases. 2016;34(4):429-437   Crossref logo
Link1 Link2

New issues in the pathogenesis of hepatocellular carcinoma: Applying insights from next-generation DNA sequencing technologies to improve therapy for hepatocellular carcinoma
Clinical Liver Disease. 2012;1(6):200-205   Crossref logo

Molecular pathogenesis of hepatocellular carcinoma
Liver International. 2007;28(2):160-174   Crossref logo

Pathogenesis of Hepatocellular Carcinoma
Digestion. 1998;59(2):60-63   Crossref logo
Link1 Link2

Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations
Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016;2961-2985   Crossref logo

Nano-Sized Drug Delivery Systems: Development and Implication in Treatment of Hepatocellular Carcinoma
Digestive Diseases. 2015;33(5):675-682   Crossref logo
Link1 Link2

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma
Cancer. 2010;116(21):5022-5029   Crossref logo